CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

CA Smith, HJ Gruss, T Davis, D Anderson, T Farrah… - Cell, 1993 - cell.com
CA Smith, HJ Gruss, T Davis, D Anderson, T Farrah, E Baker, GR Sutherland, CI Brannan…
Cell, 1993cell.com
CD30 is a surface marker for neoplastic cells of Hodgkin's lymphoma and shows sequence
homology to members of the tumor necrosis factor (TNF) receptor superfamily. Using a
chimeric probe consisting of the extracellular domain of CD30 fused to truncated
immunoglobulin heavy chains, we expression cloned the cDNA cognate from the murine T
cell clone 789. The encoded protein is a 239 amino acid type II membrane protein whose C-
terminal domain shows significant homology to TNFa, TNFf3, and the CD40L …
Summary
CD30 is a surface marker for neoplastic cells of Hodgkin’s lymphoma and shows sequence homology to members of the tumor necrosis factor (TNF) receptor superfamily. Using a chimeric probe consisting of the extracellular domain of CD30 fused to truncated immunoglobulin heavy chains, we expression cloned the cDNA cognate from the murine T cell clone 789. The encoded protein is a 239 amino acid type II membrane protein whose C-terminal domain shows significant homology to TNFa, TNFf3, and the CD40L. Crosshybridization to an induced peripheral blood T cell cDNA library yielded the human homolog, which is 72% identical at the amino acid level. The recombinant human ligand enhances the proliferation of CD3-‘activated T cells yet induces differential responses, including cell death, in several CD30+ lymphomaderived clones. The human and murine genes map to 9933 and the proximal region of chromosome 4, respectively.
cell.com